These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2894340)

  • 1. The effect of dopaminergic blockade on thyrotrophin response to thyrotrophin-releasing hormone and somatostatin.
    Sánchez A; Montoya E
    Horm Metab Res; 1987 Dec; 19(12):604-5. PubMed ID: 2894340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic control of the rat thyrotroph.
    Price J; Grossman A; Besser GM; Rees LH
    Neuroendocrinology; 1983 Feb; 36(2):125-9. PubMed ID: 6132345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of influence of the antidopaminergic drug domperidone on basal and TRH-stimulated TSH-serum levels after oral administration.
    Wenzel KW; Döring J
    Acta Endocrinol (Copenh); 1982 Dec; 101(4):550-4. PubMed ID: 6818805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of somatostatin and/or dopamine in basal and TRH-stimulated TSH release in food-restricted rats.
    Rodriguez F; Jolin T
    Acta Endocrinol (Copenh); 1991 Aug; 125(2):186-91. PubMed ID: 1680265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of domperidone on prolactin (PRL)and thyrotrophin (TSH) secretion.
    Kaufman JM; Elewaut A; Vermeulen A
    Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):293-303. PubMed ID: 6802092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
    Michalkiewicz M; Suzuki M; Kato M
    Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade.
    Ghigo E; Goffi S; Molinatti GM; Camanni F; Massara F
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):155-60. PubMed ID: 3931942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
    Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
    Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions among epinephrine, thyrotropin (TSH)-releasing hormone, dopamine, and somatostatin in the control of TSH secretion in vitro.
    Dieguez C; Foord SM; Peters JR; Hall R; Scanlon MF
    Endocrinology; 1984 Mar; 114(3):957-61. PubMed ID: 6141935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin alpha- and beta-subunit responses to thyrotropin-releasing hormone and domperidone in normal subjects and in patients with microprolactinomas.
    Persani L; Beck-Peccoz P; Medri G; Conti A; Faglia G
    Neuroendocrinology; 1991 Apr; 53(4):411-5. PubMed ID: 1710792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic control of TSH secretion in endogenous depression.
    Marchesi C; Chiodera P; De Risio C; Dassò L; Govi AM; De Ferri A; Piagneri B; Minelli R; Bianconi L; Gnudi A
    Psychiatry Res; 1988 Sep; 25(3):277-82. PubMed ID: 3141942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oestrogen (mestranol) on the thyrotrophin response to thyrotrophin releasing hormone in postmenopausal oophorectomised women.
    Abdalla HI; Beastall GH; Hart DM
    Clin Endocrinol (Oxf); 1984 Jul; 21(1):65-9. PubMed ID: 6430605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the interaction between thyrotropin-releasing hormone and somatostatin for thyrotropin and prolactin release.
    Drouin J; De Léan A; Rainville D; Lachance R; Labrie F
    Endocrinology; 1976 Feb; 98(2):514-21. PubMed ID: 813994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma prolactin levels in ovariectomized thyroidectomized rats treated with estrogen.
    Pan JT; Chen CW
    Endocrinology; 1990 Jun; 126(6):3146-52. PubMed ID: 1972060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of thyrotrophin release from an intracellular pool by pre-exposure to thyrotrophin-releasing hormone and dibutyryl cyclic AMP.
    Davis JR; Sheppard MC
    J Endocrinol; 1986 Feb; 108(2):211-7. PubMed ID: 3005459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dopamine and a dopamine D-1 receptor agonist on pulsatile thyrotrophin secretion in normal women.
    Boesgaard S; Hagen C; Hangaard J; Andersen AN; Eldrup E
    Clin Endocrinol (Oxf); 1990 Apr; 32(4):423-31. PubMed ID: 1971778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects.
    Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL
    Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin-28 inhibits thyroid-stimulating hormone release in man.
    Klaff LJ; Barron JL; Levitt NS; Ling N; Millar RP
    S Afr Med J; 1982 Dec; 62(25):929-30. PubMed ID: 6128803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small dose of domperidone potentiated the effects of TRH and serotonin on prolactin release in ovariectomized, estrogen-treated rats.
    Pan JT; Teo KL
    Neuroendocrinology; 1989 Oct; 50(4):387-91. PubMed ID: 2510048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.